Walsuronoid B is primarily studied for its potential anti-inflammatory and anticancer properties. It has shown inhibitory effects on certain signaling pathways involved in tumor growth, making it a candidate for cancer drug development research. The compound also exhibits activity against oxidative stress, suggesting possible use in formulations aimed at reducing cellular damage. Due to its natural origin and structural complexity, it serves as a lead compound in designing derivatives with enhanced bioactivity and selectivity. Current applications remain in the preclinical research phase, focusing on pharmacological evaluation and mechanism of action studies.